|
2024
|
Invention
|
Naphthyl-substituted pyrido[4,3-d]pyrimidines and related compounds and their use in treating med... |
|
|
Invention
|
Tead inhibitors and uses thereof in the treatment of proliferative disorders. The present disclos... |
|
|
Invention
|
Combinations comprising mek inhibitors for use in the treatment of cancer. The present disclosure... |
|
2023
|
Invention
|
Mek inhibitors and uses thereof.
The present disclosure provides MEK inhibitors, compositions th... |
|
|
Invention
|
Combination of tead inhibitors and egfr inhibitors and uses thereof. The present disclosure provi... |
|
|
Invention
|
Naphthyl-substituted pyranopyrimidinones and related compounds and their use in treating medical ... |
|
|
Invention
|
Tead inhibitors and uses thereof.
The present invention provides compounds, compositions thereof... |
|
|
Invention
|
Mek inhibitors and uses thereof. The present disclosure provides MEK inhibitors, compositions the... |
|
|
Invention
|
Polymorphic compounds and uses thereof. The present disclosure provides crystalline forms of the ... |
|
2022
|
Invention
|
Tead inhibitors and uses thereof. The present invention provides TEAD inhibitors, formulations an... |
|
|
Invention
|
Tead inhibitors and uses thereof. The present invention provides methods for selecting a cancer p... |
|
|
Invention
|
Tead inhibitors and uses thereof. The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Mek inhibitors and uses thereof. The present invention provides MEK inhibitors of formula (I'), c... |
|
|
Invention
|
Naphthyl-substituted quinoline-4(1h)-ones and related compounds and their use in treating medical... |
|
|
Invention
|
Substituted 4-piperidinyl-imidazo[4,5-b]pyridines and related compounds and their use in treating... |
|
|
Invention
|
Substituted 3-piperidinyl-pyrazolo[3,4-b]pyridines and related compounds and their use in treatin... |
|
|
Invention
|
Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide tead inhibitor with an egfr inhib... |
|
2021
|
Invention
|
Aryl hydrocarbon receptor (ahr) agonists and uses thereof. The present invention provides AHR ago... |
|
|
Invention
|
Tead degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Combination of an ahr inhibitor with a pdx inhibitor or doxorubicine. The present invention provi... |
|
|
Invention
|
Substituted 4-piperidinyl-quinazolines, 4-piperidinyl-pyrimidine-2-amines, and related compounds ... |
|
|
Invention
|
Substituted pyrido[2,3-b]pyrazinones and reuated compounds and their use in treating medicau cond... |
|
|
Invention
|
Substituted 4-piperidinyl-pyrrolo[2,3-b]pyridines and related compounds and their use in treating... |
|
|
Invention
|
Substituted 3-piperidinyl-pyrrolo[2,3-b]pyridines and related compounds and their use in treating... |
|
|
Invention
|
Ahr inhibitors and uses thereof. The present invention provides methods for selecting a cancer pa... |
|
2020
|
Invention
|
Aryl hydrocarbon receptor (ahr) agonists and uses thereof.
The present invention provides AHR ag... |
|
|
Invention
|
4-phenyl-n-(phenyl)thiazol-2-amine derivatives and related compounds as aryl hydrocarbon receptor... |
|
|
Invention
|
2-(1h-indole-3-carbonyl)-thiazole-4-carboxamide derivatives and related compounds as aryl hydroca... |
|
|
Invention
|
Polymorphic carbazole derivatives and uses thereof. The present invention provides freebase and s... |
|
|
Invention
|
Ahr inhibitors and uses thereof. The present invention provides AHR inhibitors, formulations and ... |
|
|
Invention
|
Pegylated kynureninase enzymes and uses thereof for the treatment of cancer. Kynureninase enzymes... |
|
2019
|
Invention
|
Indole ahr inhibitors and uses thereof. The present invention provides compounds useful as inhibi... |
|
|
G/S
|
Research and development in the pharmaceutical and biotechnology fields; Clinical research in the... |
